16. Restatement of Prior Period Financials (Details) (USD $)	3 Months Ended	10 Months Ended	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Balance Sheet
Total Assets	$ 2,526,925	$ 2,526,925	$ 882,433
Derivative liability	1,147,640	1,147,640	0
Accounts payable and accrued expenses	26,813	26,813	42,341
Convertible notes payable (net of debt discount) - current portion	5,927	5,927	5,356
Total current liabilities	1,180,380	1,180,380	48,568
Total long-term liabilities	658,733	658,733	611,200
Total liabilities	1,839,113	1,839,113	659,768
Common stock	2,604,696	2,604,696	933,627
Total Liabilities & Stockholders' Equity	2,526,925	2,526,925	882,433
Statement of Changes in Stockholders’ Equity
Common stock	2,604,696	2,604,696	933,627
Deficit accumulated during development stage	(1,916,884)	(1,916,884)	(710,962)
Statement of Operations
General and administrative expense	54,476	107,741
Operating loss from operations	(204,167)	(915,421)
Amortization of debt discount	(304,841)	(305,635)
Gain (loss) on derivative liability, net	(647,640)	(647,640)
Total other expense	(1,001,755)	(1,003,420)
Loss from continuing operations	(1,205,922)	(1,918,841)
Net loss per share - basic and diluted	$ (0.09)
Statement of Changes in Cash Flows
Amortization of debt discount	304,841	305,635
Amortization of deferred financing costs	6,000	6,000
(Gain) loss on derivative liability, net	647,640	647,640
Net cash provided by (used in) operating activities – continuing operations	(329,983)	(809,183)
Net cash provided by (used in) operating activities	(329,983)	(819,054)
Principal repayment on convertible notes payable	1,737	1,737
As Previously Reported
Balance Sheet
Deferred financing costs, net	115,000	115,000
Total Assets	2,532,925	2,532,925
Derivative liability	0	0
Accounts payable and accrued expenses	32,813	32,813
Convertible notes payable (net of debt discount) - current portion			2,930
Total current liabilities	38,740	38,740	46,142
Convertible notes payable (net of debt discount), less current portion	402,595	402,595	341,907
Total long-term liabilities	403,845	403,845	343,157
Total liabilities	442,585	442,585
Common stock	3,375,165	3,375,165	1,204,096
Accumulated deficit	(1,284,825)	(1,284,825)
Total stockholders' equity	2,090,340	2,090,340	493,134
Total Liabilities & Stockholders' Equity	2,532,925	2,532,925
Statement of Changes in Stockholders’ Equity
Discount on convertible notes December 27, 2013		289,811	289,811
Warrants sold to Full Circle		500,000
Net income (loss) for the three months ended March 31, 2014	(573,863)
Common stock	3,375,165	3,375,165	1,204,096
Total stockholders' equity	2,090,340	2,090,340	493,134
Statement of Operations
Amortization of debt discount	(320,422)	(321,216)
Gain (loss) on derivative liability, net	0	0
Total other expense	(369,696)	(371,361)
Loss from continuing operations		(1,286,782)
Net loss	(573,863)
Net loss per share - basic and diluted	$ (0.04)
Statement of Changes in Cash Flows
Net loss	(573,863)
Amortization of debt discount	320,422	321,216
Amortization of deferred financing costs	0	0
(Gain) loss on derivative liability, net	0	0
Increase/ (decrease) in accounts payable and accrued expenses	(11,193)	32,019
Net cash provided by (used in) operating activities – continuing operations	(330,777)	(809,977)
Net cash provided by (used in) operating activities	(330,777)	(819,848)
Principal repayment on convertible notes payable	(943)	(943)
Adjustments
Balance Sheet
Deferred financing costs, net	(6,000)	(6,000)
Total Assets	(6,000)	(6,000)
Derivative liability	1,147,640	1,147,640
Accounts payable and accrued expenses	(6,000)	(6,000)
Convertible notes payable (net of debt discount) - current portion			2,426
Total current liabilities	1,141,640	1,141,640	2,426
Convertible notes payable (net of debt discount), less current portion	254,888	254,888	268,043
Total long-term liabilities	254,888	254,888	268,043
Total liabilities	1,396,528	1,396,528
Common stock	(770,469)	(770,469)	(270,469)
Accumulated deficit	(632,059)	(632,059)
Total stockholders' equity	(1,402,528)	(1,402,528)	(270,469)
Total Liabilities & Stockholders' Equity	(6,000)	(6,000)
Statement of Changes in Stockholders’ Equity
Discount on convertible notes December 27, 2013		(270,469)	(270,469)
Warrants sold to Full Circle		(500,000)
Net income (loss) for the three months ended March 31, 2014	(632,059)
Common stock	(770,469)	(770,469)	(270,469)
Total stockholders' equity	(1,402,528)	(1,402,528)	(270,469)
Statement of Operations
Amortization of debt discount	15,581	15,581
Gain (loss) on derivative liability, net	(647,640)	(647,640)
Total other expense	(632,059)	(632,059)
Loss from continuing operations		(632,059)
Net loss	(632,059)
Net loss per share - basic and diluted	$ (0.05)
Statement of Changes in Cash Flows
Net loss	(632,059)
Amortization of debt discount	(15,581)	(15,581)
Amortization of deferred financing costs	6,000	6,000
(Gain) loss on derivative liability, net	647,640	647,640
Increase/ (decrease) in accounts payable and accrued expenses	(5,206)	(5,206)
Net cash provided by (used in) operating activities – continuing operations	794	794
Net cash provided by (used in) operating activities	794	794
Principal repayment on convertible notes payable	(794)	(794)
As Restated
Balance Sheet
Deferred financing costs, net	109,000	109,000
Total Assets	2,526,925	2,526,925
Derivative liability	1,147,640	1,147,640
Accounts payable and accrued expenses	26,813	26,813
Convertible notes payable (net of debt discount) - current portion			5,356
Total current liabilities	1,180,380	1,180,380	48,568
Convertible notes payable (net of debt discount), less current portion	657,483	657,483	609,950
Total long-term liabilities	658,733	658,733	611,200
Total liabilities	1,839,113	1,839,113
Common stock	2,604,696	2,604,696	933,627
Accumulated deficit	(1,916,884)	(1,916,884)
Total stockholders' equity	687,812	687,812	222,665
Total Liabilities & Stockholders' Equity	2,526,925	2,526,925
Statement of Changes in Stockholders’ Equity
Discount on convertible notes December 27, 2013		19,342	19,342
Warrants sold to Full Circle		0
Net income (loss) for the three months ended March 31, 2014	(1,205,922)
Common stock	2,604,696	2,604,696	933,627
Total stockholders' equity	687,812	687,812	222,665
Statement of Operations
Amortization of debt discount	(304,841)	(305,635)
Gain (loss) on derivative liability, net	(647,640)	(647,640)
Total other expense	(1,001,755)	(1,003,420)
Loss from continuing operations		(1,918,841)
Net loss	(1,205,922)
Net loss per share - basic and diluted	$ (0.09)
Statement of Changes in Cash Flows
Net loss	(1,205,922)
Amortization of debt discount	304,841	305,635
Amortization of deferred financing costs	6,000	6,000
(Gain) loss on derivative liability, net	647,640	647,640
Increase/ (decrease) in accounts payable and accrued expenses	(16,399)	26,813
Net cash provided by (used in) operating activities – continuing operations	(329,983)	(809,183)
Net cash provided by (used in) operating activities	(329,983)	(819,054)
Principal repayment on convertible notes payable	$ (1,737)	$ (1,737)